Ariadna Capasso is senior technical advisor for the FCI Program of Management Sciences for Health (MSH). This post originally appeared on the MSH Health Impact Blog.
Over the past year, Tijuana, Mexico, has seen an influx of U.S.-bound Haitian migrants fleeing communities left in disrepair from the 2010 earthquake and further devastated by Hurricane Matthew in October 2016. These migrants often begin their journey in Latin America and trek through multiple countries and hostile terrain only to find they cannot enter the U.S. once at the border. Among the stalled Haitian migrants living in makeshift shelters as they contemplate their next steps, pregnant women face another uncertainty: whether they or their baby will languish during pregnancy and childbirth without access to skilled maternal and newborn health care. Recognizing this health crisis, a group of midwives, Parteras Fronterizas (Borderland Midwives in English), arrived on the scene to provide antenatal and safe childbirth care, with help from women who translated from Spanish or English to Haitian Creole.
Parteras Fronterizas embodies the reason we celebrate the International Day of the Midwife–to honor the many midwives around the world who work on the frontlines to deliver high-quality, respectful care to women and newborns during pregnancy and childbirth. At the Third Regional Forum of the Mexican Midwifery Association in late April 2017, traditional and professional midwives, medical doctors, health managers, doulas and midwifery students gathered together to share midwifery practices and strategies for advancing the midwifery profession in Mexico.
Earlier this month, global health experts (and students aspiring to be experts) from around the world gathered for a series of presentations, panels and posters at the 2017 Consortium of Universities for Global Health (CUGH) Conference in Washington, D.C. The panel titled “Perspectives on Monitoring Progress Toward Ending Preventable Maternal Mortality: What Measures Matter?” provided an opportunity to discuss the monitoring framework developed to accompany the Strategies toward ending preventable maternal mortality (EPMM) report released in 2015. The panel was moderated by Mary Ellen Stanton, Senior Maternal Health Advisor at USAID, and included Rima Jolivet, Maternal Health Technical Director of the Maternal Health Task Force, Elahi Chowdhury of icddr,b (Bangaldesh) and Chibugo Okoli of the Maternal Child Survival Program (MCSP, Nigeria). Representing maternal health monitoring at the global, national and facility-levels respectively, the panelists provided insights from their unique perspectives and highlighted the importance of the EPMM monitoring framework. Continue reading “Perspectives on Monitoring Progress Toward Ending Preventable Maternal Mortality: Highlights from CUGH 2017”
Fatimata Kané est directrice du programme FCI de MSH au Mali.
Mettre un enfant au monde est tout un travail différent. Tout le monde peut aider quelqu’un qui est malade, mais tout le monde ne peut pas faire le travail d’une sage-femme–guider une femme et son bébé en toute sécurité pendant la grossesse et l’accouchement. Je sais ce que signifie garder les femmes et les bébés vivants et en bonne santé parce que je suis une sage-femme. Continue reading “Femmes saines, nations en santé”
On March 15, 2017, Management Sciences for Health (MSH), the Ministry of Foreign Affairs of Denmark, Women Deliver, Novo Nordisk, and the NCD Alliance, of which MSH is a steering committee member, hosted a panel discussion during the Commission on the Status of Women to call for the integration of the prevention and treatment of non-communicable diseases (NCDs) into the reproductive, maternal, newborn, child, and adolescent health continuum of care. The following post summarizes the key messages from the side event and offers recommendations for further action.
There has been some confusion recently about the Sustainable Development Goals (SDG) target for reducing global maternal mortality. The SDG global target is to reduce the global maternal mortality ratio (MMR) to less than 70 per 100,000 live births by 2030. In addition to this global target, there are separate country-level targets: The primary national target is that by 2030, every country should reduce its MMR by at least two-thirds from its 2010 baseline. The secondary target, which applies to countries with the highest maternal mortality burdens, is that no country should have an MMR greater than 140 deaths per 100,000 live births by 2030.
This interview with Kiley Workman Diop originally appeared on the blog for Systems for Improved Access to Pharmaceuticals and Services (SIAPS), a program funded by USAID and implemented by Management Sciences for Health. This interview has been edited for length.
Kiley Workman Diop is a Technical Advisor for SIAPS, and Stacy Lu is a Technical Writer for SIAPS.
How does attention to gender figure into the work SIAPS does in strengthening pharmaceutical systems?
In public health, when you’re designing an intervention you’re trying to think broadly about what’s going to help the whole population. But you also need to pay special attention to vulnerable groups, including groups that derive their vulnerability from their gender. In a broad sense, it’s about equity—if half the population (whether men or women, boys or girls) isn’t being served appropriately by our interventions, that dilutes SIAPS’s success and we miss out on achieving equitable access to medicines and services that help save lives. We have to think about gender to ensure equitable access to quality care.
This month, the FCI Program of MSH is featuring stories about fearless champions, powerful evidence, and advocacy wins from the Rights & Realities archive. Here is a recap of the fearless stories we shared on Twitter and Facebook February 1 -10.
Alanna Savage is a Senior Communications Specialist for the FCI Program of Management Sciences for Health (MSH) and Andrew Gaydos is a Project Support Associate at MSH.
In our ambitious vision to reach all people, everywhere, it is ever more necessary to examine the varying life experiences–the actual realities–of the people whose health we work to improve. Part of this examination requires a critical look at how gender plays out in the power structures of society, the daily lives of people, and more concretely, in the “who, what, where, when, and how” of health-seeking behavior and access to essential reproductive and maternal health care.
Maternal mortality in Mali remains high–587 women die for every 100,000 live births–but only 28 percentof sexually active women of reproductive have satisfied their demand for family planning. Women and girls continue to confront widespread sexual and gender-based violence, including female genital mutilation/cutting (FGM/C); in 2015, about 126,000 women and girls received prevention services, protection, and care related to FGM/C. And thanks to the work of the FCI Program of MSH, traditional and faith leaders are advocating for family planning and coming together to provide support to survivors of gender-based violence and to identify early warning signs of imminent violence.
Gender inequality undoubtedly plays a role in high maternal mortality and unmet need for family planning and the continuance of sexual and gender-based violence. As long as women and girls must continue to fight for equal voice and an equal share of opportunity and power, their lives and health will remain under threat. Gender influences health outcomes, access to care, providers’ treatment of patients, relationships among health workers and supervisors, and health career barriers and opportunities.
We are celebrating Fearless February to rally the global community around advocacy for reproductive, maternal, newborn, child and adolescent health!
This month, the FCI Program of MSH will feature stories about fearless champions, powerful evidence, and advocacy wins from the Rights & Realities archive. Follow #FearlessFeb on Twitter and Facebook to read the story of the day.